Search Within

Mark L Heaney

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. Biostatistics Service (12)
  2. Epidemiology and Biostatistics (12)
  3. Center for Hematologic Malignancies (8)
  4. Department of Medicine (8)
  5. Hematologic Malignancies, Division of (8)
  6. Adult Leukemia (7)

More Groups

People
  1. David Scheinberg (7)
  2. Joseph Jurcic (7)
  3. Jeffrey Gardner (6)
  4. Peter Maslak (6)
  5. Renier Brentjens (6)
  6. Mithat Gonen (5)

More People

Years
  1. 2014 (1)
  2. 2013 (1)
  3. 2012 (1)
  4. 2011 (1)
  5. 2010 (1)
  6. 2009 (1)

More Years

Publications
  1. Blood (5)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. British Journal of Surgery (1)
  5. Cancer Research (1)
  6. Clinical Lymphoma, Myeloma and Leukemia (1)
Publishers
  1. American Society of Hematology (5)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Inc. (1)
  5. Oxford University Press (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Indications for and efficacy of splenectomy for haematological disorders
    Journal Article

    Bickenbach, K. A.; Gonen, M.; Labow, D. M.; Strong, V.; Heaney, M. L.; Zelenetz, A. D.; Coit, D. G.
    British Journal of Surgery (2013)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
    Journal Article

    Paoluzzi, L.; Gonen, M.; Gardner, J. R.; Mastrella, J.; Yang, D.; Holmlund, J.; Sorensen, M.; Leopold, L.; Manova, K.; Marcucci, G.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
    Journal Article

    Paoluzzi, L.; Gonen, M.; Bhagat, G.; Furman, R. R.; Gardner, J. R.; Scotto, L.; Gueorguiev, V. D.; Heaney, M. L.; Manova, K.; O'Connor, O. A.
    Blood (2008)

    Fulltext@MSK | Save
  • Targeting anti-apoptotic bcl-2 family members with ABT-737 compliments the activity of bortezomib and conventional agents in in vitro models of lymphoproliferative malignancies
    Meeting Abstract

    Paoluzzi, L.; Gonen, M.; Gardner, J. R.; Heaney, M.; O'Connor, O. A.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
    Journal Article

    Toner, L. E.; Vrhovac, R.; Smith, E. A.; Gardner, J.; Heaney, M.; Gonen, M.; Teruya-Feldstein, J.; Sirotnak, F.; O'Connor, O. A.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save